You can buy or sell Tricida and other stocks, options, and ETFs commission-free!
Tricida, Inc. Common Stock, also called Tricida, is a pharmaceutical company. It focuses on the development and commercialization of its product, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease. The company was founded by Gerrit Klaerner and Craig Jon Hawker in 2013 and is headquartered in South San Francisco, CA. The listed name for TCDA is Tricida, Inc. Common Stock.
South San Francisco, California
52 Week High
52 Week Low
— per share
Expected Feb 25, After Hours